Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Moderna Norway AS
AS
Active
Org 828882082
Bryggegata 6, 0250
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2022 · 4 years old
1 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Moderna Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
7M
6M
4M
2M
0M
2022: 0M
0M
2022
2023: 4M
4M
2023
2024: 4M (0% vs 2023)
4M
0%
2024
2025: 6M (+50% vs 2024)
6M
+50%
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
Revenue
6 121
3 806
3 620
0
Staff expenses
−4 120
−2 918
−1 715
−0
EBITDA
322
177
184
−200
Depreciation & amort.
−10
−10
−5
−0
EBIT
312
168
179
−200
Net financials
46
−5
227
−263
Profit before tax
358
163
407
−463
Tax
303
178
131
−103
Net profit
54
−16
276
−360
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
Total assets
7 301
5 030
4 348
2 940
Equity
3 063
3 009
3 024
2 748
Long-term debt
0
0
0
0
Short-term debt
4 238
2 022
1 324
192
Total debt
4 238
2 022
1 324
192
Financial ratios
5-year trend
EBITDA margin
5,3 %
This company
15,8 %
Market median
This company
Market median
66% below market
2022
2025
Equity ratio
42,0 %
This company
38,2 %
Market median
This company
Market median
10% above market
2022
2025
Return on equity
1,8 %
This company
18,4 %
Market median
This company
Market median
90% below market
2022
2025
Net profit margin
0,9 %
This company
8,1 %
Market median
This company
Market median
89% below market
2022
2025
Asset turnover
0,84×
This company
1,12×
Market median
This company
Market median
25% below market
2022
2025
Debt / equity
1,38×
This company
0,62×
Market median
This company
Market median
123% above market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-02-01 – 2022-12-31
View
PDF
More on Moderna Norway AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
